Long-term use of the levonorgestrel-releasing intrauterine system

Contraception

Volumn 75, Issue 6 SUPPL., 2007, Pages

  Inki, Pirjo ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Heavy bleeding; LNG IUS; Long term; Menopausal; Menorrhagia; Repeat use

Indexed keywords

CONJUGATED ESTROGEN; COPPER INTRAUTERINE DEVICE; DANAZOL; ESTRADIOL VALERATE; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MEFENAMIC ACID; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; TRANEXAMIC ACID;

AMENORRHEA; BLEEDING; CLIMACTERIUM; CLINICAL TRIAL; DRUG RELEASE; DRUG TOLERABILITY; DRUG USE; ESTROGEN THERAPY; FOLLOW UP; HUMAN; HYSTERECTOMY; INTRAUTERINE CONTRACEPTIVE DEVICE; MENORRHAGIA; MENSTRUAL IRREGULARITY; PAIN; QUALITY OF LIFE; REVIEW;

ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; LONGITUDINAL STUDIES; MENOPAUSE; MENORRHAGIA; PROGESTINS; RANDOMIZED CONTROLLED TRIALS; STERILIZATION, REPRODUCTIVE;

EID: 34248678436     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.12.016     Document Type: Review

References (42)

1. Sitruk-Ware R., and Inki P. The levonorgestrel intrauterine system - long-term contraception and therapeutic effects. Women's Health 1 (2005) 171-182
2. Hurskainen R., Teperi J., Rissanen P., et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial five-year follow-up. JAMA 271 (2004) 1456-1463
3. Mattinson A., and Mansour D. Female sterilisation: is it what women really want or are alternative contraceptive methods acceptable?. J Fam Plann Reprod Health Care 32 (2006) 181-183
4. Reid P.C., and Mukri F. Trends in number of hysterectomies performed for menorrhagia in England: examination of health episode statistics, 1989 to 2002-3. BMJ 330 (2005) 938-989
5. Rönnerdag M., and Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. Acta Obstet Gynecol Scand 78 (1999) 716-721
6. Andersson K., Odlind V., and Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception 49 (1994) 56-72
7. Aubeny E. Will period-free hormonal contraception become the norm of the twenty-first century?. Eur J Contracept Reprod Health Care 11 (2006) 1-5
8. Ferrero S., Abbamonte L.H., Giordano M., et al. What is the desired menstrual frequency of women without menstruation-related symptoms?. Contraception 73 (2006) 537-541
9. Backman T., Huhtala S., Blom T., Luoto R., Rauramo I., and Koskenvuo M. Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users. BJOG 107 (2000) 335-339
10. Baldaszti E., Wimmer Puchinger B., and Loeschke K. Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study. Contraception 67 (2003) 87-91
11. Sivin I., El Mahgoub S., McCarthy T., et al. Long-term contraception with the levonorgestrel 20 mcg/day (LNG 20) and the copper T 380Ag intrauterine devices: a five-year randomized study. Contraception 42 (1990) 361-378
12. Farley T.M.M., and Schmidt J. WHO Department of Reproductive Health and Research Annual Technical Report 2003. Safety and effectiveness of existing methods of fertility regulation (2003), WHO, Geneva 58-61
13. Backman T., Huhtala S., Luoto R., Tuominen J., Rauramo I., and Koskenvuo M. Advance information improves user satisfaction with the levonorgestrel intrauterine system. Obstet Gynecol 99 (2002) 608-613
14. Cooper K.G., Jack S.A., Parkin D.E., and Grant A.M. Five-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes. BJOG 108 (2001) 1222-1228
15. Coulter A., Bradlow J., Agass M., Martin-Bates C., and Tulloch A. Outcomes of referrals to gynaecology outpatient clinics for menstrual problems: an audit of general practice records. BJOG 98 (1991) 789-796
16. Lethaby A., Irvine G., and Cameron I. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst Rev 2 (2000) CD001016
17. Radesic B., and Sharma A. Levonorgestrel-releasing intrauterine system for treating menstrual disorders: a patient satisfaction questionnaire. Aust New Zealand J Obst Gyn 44 (2004) 247-251
18. Reid P.C., and Virtanen-Kari S. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. BJOG 112 (2005) 1121-1125
19. Hurskainen R., Teperi J., Rissanen P., et al. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet 357 (2001) 273-277
20. Mukherjee K., and Jones K. The treatment of dysfunctional uterine bleeding with the Mirena IUS: a survival analysis. Gynecol Surg 2 (2005) 251-254
21. Busfield R.A., Farquhar C.M., Sowter M.C., et al. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding. BJOG 113 (2006) 257-263
22. Lethaby A, Hickey M, Garry R. Endometrial destruction techniques for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD001501. DOI: 10.1002/14651858.CD001501.pub2.
23. Seidman D.S., Bitman G., Mashiach S., Hart S., and Goldenberg M. The effect of increasing age on the outcome of hysteroscopic endometrial resection for management of dysfunctional uterine bleeding. J Am Assoc Gynecol Laparosc 7 (2000) 115-119
24. Pugh C.P., Crae J.M., and Hogan T.G. Successful intrauterine pregnancy after endometrial ablation. J Am Assoc Gynecol Laparosc 7 (2000) 391-394
25. Gervaise A., deTayrac R., and Fernandez H. Contraceptive information after endometrial ablation. Fertil Steril 84 (2005) 1746-1747
26. Lo J.S., and Pickersgill A. Pregnancy after endometrial ablation: English literature review and case report. J Minim Invasive Gynecol 13 (2006) 88-91
27. Mall A., Shirk G., and Van Voorhis B.J. Previous tubal ligation is a risk factor for hysterectomy after rollerball endometrial ablation. Obstet Gynecol 100 (2002) 659-664
28. McCausland A.M., and McCausland V.M. Frequency of symptomatic cornual hematometra and postablation tubal sterilization syndrome after total rollerball endometrial ablation: a 10-year follow-up. Am J Obstet Gynecol 186 (2002) 1274-1280
29. Zapantis G., and Santoro N. The menopausal transition: characteristics and management. Best Pract Res Clin Endocrinol Metab 17 (2003) 33-52
30. Boon J., Scholten P.C., Oldenhave A., and Heintz A.P. Continuous intrauterine compared with cyclic oral progestin administration in perimenopausal HRT. Maturitas 46 (2003) 69-77
31. Hampton N.R., Rees M.C., Lowe D.G., Rauramo I., Barlow D., and Guillebaud J. Levonorgestrel intrauterine system (LNG-IUS) with conjugated oral equine estrogen: a successful regimen for HRT in perimenopausal women. Hum Reprod 20 (2005) 2653-2660
32. Suhonen S., Haukkamaa M., Jakobsson T., and Rauramo I. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. Contraception 69 (2004) 407-412
33. Luukkainen T., Haukkamaa M., Lähteenmäki P., and Toivonen J. The levonorgestrel-releasing IUD. In: Talwar G.P. (Ed). Contraception research for today and the nineties Vol. 1 (1988), Springer Verlag, Berlin 37-48
34. Bahamondes L., Espejo-Arce X., Hidalgo M.M., Hidalgo-Regina C., Teatin-Juliano C., and Petta C. A cross-sectional study of the forearm bone density of long-term users of levonorgestrel-releasing intrauterine system. Hum Reprod 21 (2006) 1316-1319
35. Halmesmäki K., Paavonen J., Tuppurainen M.T., and Hurskainen R.A. Randomized controlled trial of the effect of hysterectomy or LNG-IUS use on bone mineral density: a five-year follow-up. Therapy 3 (2006) 509-515
36. Vercellini P., Aimi G., Panazza S., DiGiorgi O., Pesole A., and Crosignani P.G. A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study. Fertil Steril 72 (1999) 505-508
37. Petta C.A., Ferriani R.A., Abrao M.S., et al. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod 20 (2005) 1993-1998
38. Grigorieva V., Chen-Mok M., Tarasova M., and Mikhailov A. Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas. Fertil Steril 79 (2003) 1194-1198
39. Inki P., Hurskainen R., Palo P., et al. Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy. Ultrasound Obstet Gynecol 20 (2002) 381-385
40. Sivin I., and Stern J. Health during prolonged use of levonorgestrel 20 μg/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. Fertil Steril 61 (1994) 70-77
41. Vereide A.B., Arnes M., Straume B., Maltau J.M., and Orbo A. Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone. Gynecol Oncol 91 (2003) 526-533
42. Clark T.J., Neelakantan D., and Gupta J.K. The management of endometrial hyperplasia: an evaluation of current practice. Eur J Obstet Gynecol Reprod Biol 125 (2006) 259-264